Enliven Therapeutics, Inc.

ELVN·NasdaqGS
Compare
40.84−0.14 (−0.34%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours40.840.00 (0.00%)Oct 12, 4:01 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close40.98
Open40.67
Day range40.5041.41
52-week range14.7962.32
Off day high−1.38%
Off 52-week high−34.47%
Volume579.82K
Avg. volume (3M)1.14M
Market cap2.99B
EPS (TTM)-1.67
Forward P/E-17.35
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding73.27M
Short interest—
Earnings dateNov 11, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ELVN AVBP TNGX IDYA SNDX CADL
Market cap 2.99B 811.61M 4.08B 3.48B 1.48B 748.35M
P/E (TTM) — — — — — —
Forward P/E -17.3 -4.2 -14.3 -9.0 -19.4 -15.6
Price/book 3.3 2.2 8.9 2.9 97.9 5.9
Dividend yield — — — — — —
1-year change +98.16% −17.70% +181.11% +34.89% +11.78% +53.63%
Today −0.34% −1.61% +1.51% −0.14% −2.59% −1.61%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ELVN news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.